Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,706
Closed -$845K 699
2024
Q2
$845K Buy
+2,706
New +$795K 0.09% 403
2020
Q2
Sell
-6,600
Closed -$1.34M 321
2020
Q1
$1.34M Buy
+6,600
New +$1.44M 0.34% 82
2019
Q4
Sell
-27,813
Closed -$5.38M 616
2019
Q3
$5.38M Sell
27,813
-45,400
-62% -$8.71M 0.28% 99
2019
Q2
$13.5M Buy
73,213
+20,613
+39% +$3.69M 0.71% 25
2019
Q1
$9.99M Buy
+52,600
New +$10M 0.53% 50
2018
Q4
Sell
-12,400
Closed -$2.57M 531
2018
Q3
$2.57M Buy
12,400
+1,900
+18% +$374K 0.16% 201
2018
Q2
$1.94M Sell
10,500
-1,800
-15% -$318K 0.13% 201
2018
Q1
$2.1M Sell
12,300
-13,100
-52% -$2.4M 0.17% 171
2017
Q4
$4.42M Buy
+25,400
New +$4.5M 0.45% 62
2017
Q3
Sell
-3,800
Closed -$654K 442
2017
Q2
$654K Sell
3,800
-29,300
-89% -$4.77M 0.09% 273
2017
Q1
$5.43M Buy
33,100
+32,700
+8,175% +$5.43M 1.05% 3
2016
Q4
$58K Sell
400
-10,000
-96% -$1.51M 0.01% 495
2016
Q3
$1.74M Sell
10,400
-400
-4% -$67.6K 0.51% 57
2016
Q2
$1.64M Buy
10,800
+9,300
+620% +$1.45M 0.56% 45
2016
Q1
$225K Sell
1,500
-3,000
-67% -$446K 0.1% 281
2015
Q4
$730K Buy
4,500
+2,200
+96% +$346K 0.5% 50
2015
Q3
$318K Sell
2,300
-3,200
-58% -$504K 0.28% 127
2015
Q2
$844K Buy
+5,500
New +$881K 1% 4
2014
Q4
Sell
-500
Closed -$70.2K 482
2014
Q3
$70.2K Sell
500
-1,600
-76% -$209K 0.05% 362
2014
Q2
$249K Buy
2,100
+100
+5% +$11.6K 0.24% 138
2014
Q1
$247K Buy
+2,000
New +$243K 0.21% 205

Other funds holding AMGN

Seven Eight Capital's AMGN Position: Q3 2024 in Review

Seven Eight Capital sold out of Amgen (AMGN) in Q3 2024, closing a stake of 2,706 shares — an estimated $845K sold.

Seven Eight Capital first reported a position in AMGN in Q1 2014 and held it in 21 quarters. The position peaked at $13.5M in Q2 2019. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Seven Eight Capital reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Seven Eight Capital sold 2,706 Amgen shares in Q3 2024, an estimated $845K.
  • Seven Eight Capital first reported a position in Amgen in Q1 2014 and held it in 21 quarters.
  • Seven Eight Capital's Amgen position peaked at $13.5M in Q2 2019.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Seven Eight Capital's 13F filing for Q3 2024, filed 12 Nov 2024.